English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 147 | Tables: 265 | Pharma & Healthcare
Human prothrombin complex concentrate, also known as factor IX complex, is a plasma-derived coagulation factor extract, which was originally used to treat factor IX deficiency, because PCC also contains coagulation factors II, VII, and X, so PCCs are more commonly used Recommended for correcting coagulation abnormalities caused by warfarin. It is mainly used for the treatment of congenital and acquired coagulation factor II, VII, IX, and X deficiency (single or combined deficiency).
The global market for Human Prothrombin Complex Concentrate was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex Concentrate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Prothrombin Complex Concentrate by region & country, by Type, and by Application.
The Human Prothrombin Complex Concentrate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex Concentrate.
Market Segmentation
By Company
Octapharma
CSL
Beijing Tiantan Biological Products Co., Ltd.
Shanghai RAAS
Biotest
Thailand Bio
Hualan Bio
Weiguang Biology
Green Cross (China) Biological Products Co., Ltd.
Beijing Bohui Innovative Biotechnology Group Co., Ltd.
Guangdong Shuanglin Biopharmaceutical Co., Ltd.
Jiangxi Boya Biopharmaceutical Co., Ltd.
Takeda
Grifols
Shanghai Emerging Pharmaceuticals
Segment by Type:
500 IU
1000 IU
Segment by Application
Hemophilia B
Vitamin K Deficiency
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Prothrombin Complex Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Prothrombin Complex Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Prothrombin Complex Concentrate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Human Prothrombin Complex Concentrate Product Introduction
1.2 Global Human Prothrombin Complex Concentrate Market Size Forecast
1.2.1 Global Human Prothrombin Complex Concentrate Sales Value (2019-2030)
1.2.2 Global Human Prothrombin Complex Concentrate Sales Volume (2019-2030)
1.2.3 Global Human Prothrombin Complex Concentrate Sales Price (2019-2030)
1.3 Human Prothrombin Complex Concentrate Market Trends & Drivers
1.3.1 Human Prothrombin Complex Concentrate Industry Trends
1.3.2 Human Prothrombin Complex Concentrate Market Drivers & Opportunity
1.3.3 Human Prothrombin Complex Concentrate Market Challenges
1.3.4 Human Prothrombin Complex Concentrate Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Prothrombin Complex Concentrate Players Revenue Ranking (2023)
2.2 Global Human Prothrombin Complex Concentrate Revenue by Company (2019-2024)
2.3 Global Human Prothrombin Complex Concentrate Players Sales Volume Ranking (2023)
2.4 Global Human Prothrombin Complex Concentrate Sales Volume by Company Players (2019-2024)
2.5 Global Human Prothrombin Complex Concentrate Average Price by Company (2019-2024)
2.6 Key Manufacturers Human Prothrombin Complex Concentrate Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Human Prothrombin Complex Concentrate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Prothrombin Complex Concentrate
2.9 Human Prothrombin Complex Concentrate Market Competitive Analysis
2.9.1 Human Prothrombin Complex Concentrate Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Prothrombin Complex Concentrate Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex Concentrate as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 500 IU
3.1.2 1000 IU
3.2 Global Human Prothrombin Complex Concentrate Sales Value by Type
3.2.1 Global Human Prothrombin Complex Concentrate Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Prothrombin Complex Concentrate Sales Value, by Type (2019-2030)
3.2.3 Global Human Prothrombin Complex Concentrate Sales Value, by Type (%) (2019-2030)
3.3 Global Human Prothrombin Complex Concentrate Sales Volume by Type
3.3.1 Global Human Prothrombin Complex Concentrate Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Human Prothrombin Complex Concentrate Sales Volume, by Type (2019-2030)
3.3.3 Global Human Prothrombin Complex Concentrate Sales Volume, by Type (%) (2019-2030)
3.4 Global Human Prothrombin Complex Concentrate Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hemophilia B
4.1.2 Vitamin K Deficiency
4.1.3 Other
4.2 Global Human Prothrombin Complex Concentrate Sales Value by Application
4.2.1 Global Human Prothrombin Complex Concentrate Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Prothrombin Complex Concentrate Sales Value, by Application (2019-2030)
4.2.3 Global Human Prothrombin Complex Concentrate Sales Value, by Application (%) (2019-2030)
4.3 Global Human Prothrombin Complex Concentrate Sales Volume by Application
4.3.1 Global Human Prothrombin Complex Concentrate Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Human Prothrombin Complex Concentrate Sales Volume, by Application (2019-2030)
4.3.3 Global Human Prothrombin Complex Concentrate Sales Volume, by Application (%) (2019-2030)
4.4 Global Human Prothrombin Complex Concentrate Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Human Prothrombin Complex Concentrate Sales Value by Region
5.1.1 Global Human Prothrombin Complex Concentrate Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Prothrombin Complex Concentrate Sales Value by Region (2019-2024)
5.1.3 Global Human Prothrombin Complex Concentrate Sales Value by Region (2025-2030)
5.1.4 Global Human Prothrombin Complex Concentrate Sales Value by Region (%), (2019-2030)
5.2 Global Human Prothrombin Complex Concentrate Sales Volume by Region
5.2.1 Global Human Prothrombin Complex Concentrate Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Human Prothrombin Complex Concentrate Sales Volume by Region (2019-2024)
5.2.3 Global Human Prothrombin Complex Concentrate Sales Volume by Region (2025-2030)
5.2.4 Global Human Prothrombin Complex Concentrate Sales Volume by Region (%), (2019-2030)
5.3 Global Human Prothrombin Complex Concentrate Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Human Prothrombin Complex Concentrate Sales Value, 2019-2030
5.4.2 North America Human Prothrombin Complex Concentrate Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Human Prothrombin Complex Concentrate Sales Value, 2019-2030
5.5.2 Europe Human Prothrombin Complex Concentrate Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Human Prothrombin Complex Concentrate Sales Value, 2019-2030
5.6.2 Asia Pacific Human Prothrombin Complex Concentrate Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Human Prothrombin Complex Concentrate Sales Value, 2019-2030
5.7.2 South America Human Prothrombin Complex Concentrate Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Prothrombin Complex Concentrate Sales Value, 2019-2030
5.8.2 Middle East & Africa Human Prothrombin Complex Concentrate Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Prothrombin Complex Concentrate Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Prothrombin Complex Concentrate Sales Value
6.2.1 Key Countries/Regions Human Prothrombin Complex Concentrate Sales Value, 2019-2030
6.2.2 Key Countries/Regions Human Prothrombin Complex Concentrate Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Human Prothrombin Complex Concentrate Sales Value, 2019-2030
6.3.2 United States Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Prothrombin Complex Concentrate Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Prothrombin Complex Concentrate Sales Value, 2019-2030
6.4.2 Europe Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Prothrombin Complex Concentrate Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Prothrombin Complex Concentrate Sales Value, 2019-2030
6.5.2 China Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Prothrombin Complex Concentrate Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Prothrombin Complex Concentrate Sales Value, 2019-2030
6.6.2 Japan Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Prothrombin Complex Concentrate Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Prothrombin Complex Concentrate Sales Value, 2019-2030
6.7.2 South Korea Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Prothrombin Complex Concentrate Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Prothrombin Complex Concentrate Sales Value, 2019-2030
6.8.2 Southeast Asia Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Prothrombin Complex Concentrate Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Prothrombin Complex Concentrate Sales Value, 2019-2030
6.9.2 India Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Prothrombin Complex Concentrate Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Octapharma
7.1.1 Octapharma Company Information
7.1.2 Octapharma Introduction and Business Overview
7.1.3 Octapharma Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Octapharma Human Prothrombin Complex Concentrate Product Offerings
7.1.5 Octapharma Recent Development
7.2 CSL
7.2.1 CSL Company Information
7.2.2 CSL Introduction and Business Overview
7.2.3 CSL Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.2.4 CSL Human Prothrombin Complex Concentrate Product Offerings
7.2.5 CSL Recent Development
7.3 Beijing Tiantan Biological Products Co., Ltd.
7.3.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
7.3.2 Beijing Tiantan Biological Products Co., Ltd. Introduction and Business Overview
7.3.3 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Offerings
7.3.5 Beijing Tiantan Biological Products Co., Ltd. Recent Development
7.4 Shanghai RAAS
7.4.1 Shanghai RAAS Company Information
7.4.2 Shanghai RAAS Introduction and Business Overview
7.4.3 Shanghai RAAS Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Shanghai RAAS Human Prothrombin Complex Concentrate Product Offerings
7.4.5 Shanghai RAAS Recent Development
7.5 Biotest
7.5.1 Biotest Company Information
7.5.2 Biotest Introduction and Business Overview
7.5.3 Biotest Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Biotest Human Prothrombin Complex Concentrate Product Offerings
7.5.5 Biotest Recent Development
7.6 Thailand Bio
7.6.1 Thailand Bio Company Information
7.6.2 Thailand Bio Introduction and Business Overview
7.6.3 Thailand Bio Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Thailand Bio Human Prothrombin Complex Concentrate Product Offerings
7.6.5 Thailand Bio Recent Development
7.7 Hualan Bio
7.7.1 Hualan Bio Company Information
7.7.2 Hualan Bio Introduction and Business Overview
7.7.3 Hualan Bio Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hualan Bio Human Prothrombin Complex Concentrate Product Offerings
7.7.5 Hualan Bio Recent Development
7.8 Weiguang Biology
7.8.1 Weiguang Biology Company Information
7.8.2 Weiguang Biology Introduction and Business Overview
7.8.3 Weiguang Biology Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Weiguang Biology Human Prothrombin Complex Concentrate Product Offerings
7.8.5 Weiguang Biology Recent Development
7.9 Green Cross (China) Biological Products Co., Ltd.
7.9.1 Green Cross (China) Biological Products Co., Ltd. Company Information
7.9.2 Green Cross (China) Biological Products Co., Ltd. Introduction and Business Overview
7.9.3 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Offerings
7.9.5 Green Cross (China) Biological Products Co., Ltd. Recent Development
7.10 Beijing Bohui Innovative Biotechnology Group Co., Ltd.
7.10.1 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information
7.10.2 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Introduction and Business Overview
7.10.3 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Offerings
7.10.5 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Development
7.11 Guangdong Shuanglin Biopharmaceutical Co., Ltd.
7.11.1 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information
7.11.2 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Introduction and Business Overview
7.11.3 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Offerings
7.11.5 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Development
7.12 Jiangxi Boya Biopharmaceutical Co., Ltd.
7.12.1 Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information
7.12.2 Jiangxi Boya Biopharmaceutical Co., Ltd. Introduction and Business Overview
7.12.3 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Offerings
7.12.5 Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Development
7.13 Takeda
7.13.1 Takeda Company Information
7.13.2 Takeda Introduction and Business Overview
7.13.3 Takeda Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Takeda Human Prothrombin Complex Concentrate Product Offerings
7.13.5 Takeda Recent Development
7.14 Grifols
7.14.1 Grifols Company Information
7.14.2 Grifols Introduction and Business Overview
7.14.3 Grifols Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Grifols Human Prothrombin Complex Concentrate Product Offerings
7.14.5 Grifols Recent Development
7.15 Shanghai Emerging Pharmaceuticals
7.15.1 Shanghai Emerging Pharmaceuticals Company Information
7.15.2 Shanghai Emerging Pharmaceuticals Introduction and Business Overview
7.15.3 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Offerings
7.15.5 Shanghai Emerging Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Human Prothrombin Complex Concentrate Industrial Chain
8.2 Human Prothrombin Complex Concentrate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Prothrombin Complex Concentrate Sales Model
8.5.2 Sales Channel
8.5.3 Human Prothrombin Complex Concentrate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Human Prothrombin Complex Concentrate Market Trends
Table 2. Human Prothrombin Complex Concentrate Market Drivers & Opportunity
Table 3. Human Prothrombin Complex Concentrate Market Challenges
Table 4. Human Prothrombin Complex Concentrate Market Restraints
Table 5. Global Human Prothrombin Complex Concentrate Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Human Prothrombin Complex Concentrate Revenue Market Share by Company (2019-2024)
Table 7. Global Human Prothrombin Complex Concentrate Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Human Prothrombin Complex Concentrate Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Human Prothrombin Complex Concentrate Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Human Prothrombin Complex Concentrate Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Human Prothrombin Complex Concentrate Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Human Prothrombin Complex Concentrate
Table 13. Global Human Prothrombin Complex Concentrate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex Concentrate as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Prothrombin Complex Concentrate Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Human Prothrombin Complex Concentrate Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Human Prothrombin Complex Concentrate Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Human Prothrombin Complex Concentrate Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Human Prothrombin Complex Concentrate Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Human Prothrombin Complex Concentrate Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Human Prothrombin Complex Concentrate Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Human Prothrombin Complex Concentrate Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Human Prothrombin Complex Concentrate Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Human Prothrombin Complex Concentrate Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Human Prothrombin Complex Concentrate Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Human Prothrombin Complex Concentrate Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Human Prothrombin Complex Concentrate Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Human Prothrombin Complex Concentrate Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Human Prothrombin Complex Concentrate Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Human Prothrombin Complex Concentrate Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Human Prothrombin Complex Concentrate Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Human Prothrombin Complex Concentrate Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Human Prothrombin Complex Concentrate Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Human Prothrombin Complex Concentrate Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Human Prothrombin Complex Concentrate Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Human Prothrombin Complex Concentrate Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Human Prothrombin Complex Concentrate Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Human Prothrombin Complex Concentrate Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Human Prothrombin Complex Concentrate Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Human Prothrombin Complex Concentrate Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Human Prothrombin Complex Concentrate Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Human Prothrombin Complex Concentrate Sales Value by Region (2019-2024) & (%)
Table 44. Global Human Prothrombin Complex Concentrate Sales Value by Region (2025-2030) & (%)
Table 45. Global Human Prothrombin Complex Concentrate Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Human Prothrombin Complex Concentrate Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Human Prothrombin Complex Concentrate Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Human Prothrombin Complex Concentrate Sales Volume by Region (2019-2024) & (%)
Table 49. Global Human Prothrombin Complex Concentrate Sales Volume by Region (2025-2030) & (%)
Table 50. Global Human Prothrombin Complex Concentrate Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Human Prothrombin Complex Concentrate Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Human Prothrombin Complex Concentrate Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Human Prothrombin Complex Concentrate Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Human Prothrombin Complex Concentrate Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Human Prothrombin Complex Concentrate Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Human Prothrombin Complex Concentrate Sales Volume, (2025-2030) & (K Units)
Table 57. Octapharma Company Information
Table 58. Octapharma Introduction and Business Overview
Table 59. Octapharma Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Octapharma Human Prothrombin Complex Concentrate Product Offerings
Table 61. Octapharma Recent Development
Table 62. CSL Company Information
Table 63. CSL Introduction and Business Overview
Table 64. CSL Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. CSL Human Prothrombin Complex Concentrate Product Offerings
Table 66. CSL Recent Development
Table 67. Beijing Tiantan Biological Products Co., Ltd. Company Information
Table 68. Beijing Tiantan Biological Products Co., Ltd. Introduction and Business Overview
Table 69. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Offerings
Table 71. Beijing Tiantan Biological Products Co., Ltd. Recent Development
Table 72. Shanghai RAAS Company Information
Table 73. Shanghai RAAS Introduction and Business Overview
Table 74. Shanghai RAAS Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Shanghai RAAS Human Prothrombin Complex Concentrate Product Offerings
Table 76. Shanghai RAAS Recent Development
Table 77. Biotest Company Information
Table 78. Biotest Introduction and Business Overview
Table 79. Biotest Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Biotest Human Prothrombin Complex Concentrate Product Offerings
Table 81. Biotest Recent Development
Table 82. Thailand Bio Company Information
Table 83. Thailand Bio Introduction and Business Overview
Table 84. Thailand Bio Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Thailand Bio Human Prothrombin Complex Concentrate Product Offerings
Table 86. Thailand Bio Recent Development
Table 87. Hualan Bio Company Information
Table 88. Hualan Bio Introduction and Business Overview
Table 89. Hualan Bio Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Hualan Bio Human Prothrombin Complex Concentrate Product Offerings
Table 91. Hualan Bio Recent Development
Table 92. Weiguang Biology Company Information
Table 93. Weiguang Biology Introduction and Business Overview
Table 94. Weiguang Biology Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Weiguang Biology Human Prothrombin Complex Concentrate Product Offerings
Table 96. Weiguang Biology Recent Development
Table 97. Green Cross (China) Biological Products Co., Ltd. Company Information
Table 98. Green Cross (China) Biological Products Co., Ltd. Introduction and Business Overview
Table 99. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Offerings
Table 101. Green Cross (China) Biological Products Co., Ltd. Recent Development
Table 102. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information
Table 103. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Introduction and Business Overview
Table 104. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Offerings
Table 106. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Development
Table 107. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information
Table 108. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Introduction and Business Overview
Table 109. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Offerings
Table 111. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Development
Table 112. Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information
Table 113. Jiangxi Boya Biopharmaceutical Co., Ltd. Introduction and Business Overview
Table 114. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Offerings
Table 116. Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Development
Table 117. Takeda Company Information
Table 118. Takeda Introduction and Business Overview
Table 119. Takeda Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Takeda Human Prothrombin Complex Concentrate Product Offerings
Table 121. Takeda Recent Development
Table 122. Grifols Company Information
Table 123. Grifols Introduction and Business Overview
Table 124. Grifols Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Grifols Human Prothrombin Complex Concentrate Product Offerings
Table 126. Grifols Recent Development
Table 127. Shanghai Emerging Pharmaceuticals Company Information
Table 128. Shanghai Emerging Pharmaceuticals Introduction and Business Overview
Table 129. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Offerings
Table 131. Shanghai Emerging Pharmaceuticals Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Human Prothrombin Complex Concentrate Downstream Customers
Table 135. Human Prothrombin Complex Concentrate Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Prothrombin Complex Concentrate Product Picture
Figure 2. Global Human Prothrombin Complex Concentrate Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Human Prothrombin Complex Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Human Prothrombin Complex Concentrate Sales Volume (2019-2030) & (K Units)
Figure 5. Global Human Prothrombin Complex Concentrate Sales Price (2019-2030) & (US$/Unit)
Figure 6. Human Prothrombin Complex Concentrate Report Years Considered
Figure 7. Global Human Prothrombin Complex Concentrate Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Human Prothrombin Complex Concentrate Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Prothrombin Complex Concentrate Revenue in 2023
Figure 10. Human Prothrombin Complex Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 500 IU Picture
Figure 12. 1000 IU Picture
Figure 13. Global Human Prothrombin Complex Concentrate Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Human Prothrombin Complex Concentrate Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Human Prothrombin Complex Concentrate Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Human Prothrombin Complex Concentrate Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Human Prothrombin Complex Concentrate Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hemophilia B
Figure 19. Product Picture of Vitamin K Deficiency
Figure 20. Product Picture of Other
Figure 21. Global Human Prothrombin Complex Concentrate Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Human Prothrombin Complex Concentrate Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Human Prothrombin Complex Concentrate Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Human Prothrombin Complex Concentrate Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Human Prothrombin Complex Concentrate Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Human Prothrombin Complex Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Human Prothrombin Complex Concentrate Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Human Prothrombin Complex Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Human Prothrombin Complex Concentrate Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Human Prothrombin Complex Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Human Prothrombin Complex Concentrate Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Human Prothrombin Complex Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Human Prothrombin Complex Concentrate Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Human Prothrombin Complex Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Human Prothrombin Complex Concentrate Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Human Prothrombin Complex Concentrate Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Human Prothrombin Complex Concentrate Sales Volume (%), (2019-2030)
Figure 38. United States Human Prothrombin Complex Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Human Prothrombin Complex Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Human Prothrombin Complex Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Human Prothrombin Complex Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 44. China Human Prothrombin Complex Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 46. China Human Prothrombin Complex Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Human Prothrombin Complex Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Human Prothrombin Complex Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Human Prothrombin Complex Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Human Prothrombin Complex Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Human Prothrombin Complex Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Human Prothrombin Complex Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 56. India Human Prothrombin Complex Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Human Prothrombin Complex Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 58. India Human Prothrombin Complex Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 59. Human Prothrombin Complex Concentrate Industrial Chain
Figure 60. Human Prothrombin Complex Concentrate Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
